EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Central nervous system infection following allogeneic hematopoietic stem cell transplantation

Ryo Hanajiri, Takeshi Kobayashi, Kosuke Yoshioka, Daisuke Watanabe, Kyoko Watakabe, Yutaka Murata, Takeshi Hagino, Yasushi Seno, Yuho Najima, Aiko Igarashi, Noriko Doki, Kazuhiko Kakihana, Hisashi Sakamaki, Kazuteru Ohashi

Hematology/Oncology and Stem Cell Therapy · 2017-01 · 10 (1) · 22-28

DOI: 10.1016/j.hemonc.2016.08.008 ↗
AbstractBibliografische Angaben

Abstract

Objective/background: Here, we described the clinical characteristics and outcomes of central nervous system (CNS) infections occurring after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in a single institution over the previous 6 years. Methods: Charts of 353 consecutive allogeneic transplant recipients were retrospectively reviewed for CNS infection. Results: A total of 17 cases of CNS infection were identified at a median of 38 days (range, 10– 1028 days) after allo-HSCT. Causative pathogens were human herpesvirus-6 ( n = 6), enterococcus ( n = 2), staphylococcus ( n = 2), streptococcus ( n = 2), varicella zoster virus ( n = 1), cytomegalovirus ( n = 1), John Cunningham virus ( n = 1), adenovirus ( n = 1), and Toxoplasma gondii ( n = 1). The cumulative incidence of CNS infection was 4.1% at 1 year and 5.5% at 5 years. Conclusion: Multivariate analysis revealed that high-risk disease status was a risk factor for developing CNS infection ( p = .02), and that overall survival at 3 years after allo-HSCT was 33% in patients with CNS infection and 53% in those without CNS infection ( p = .04).

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →